Home > Animal Health & Nutrition > Veterinary Medical Devices > Bovine Tuberculosis Diagnosis Market
The global bovine tuberculosis diagnosis market size was valued at USD 795.5 million in 2023 and is estimated to grow at a CAGR of 7.5% from 2024 to 2032. The growing demand for bovine tuberculosis diagnosis is driven by several key factors, including the rising global prevalence of bovine tuberculosis and significant advancements in diagnostic technologies.
Stringent government regulations and initiatives play a crucial role in driving the market, as governments worldwide enforce stricter testing protocols to prevent the spread of bovine tuberculosis. For example, in 2023, the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) mandated more rigorous testing and reporting standards, reflecting the heightened emphasis on disease control in livestock. Additionally, the increasing consumption of dairy products is driving demand for healthier cattle herds, further necessitating effective bovine tuberculosis diagnostic tests to ensure public health safety.
Bovine tuberculosis diagnosis refers to the process of detecting the presence of Mycobacterium bovis in cattle. This bacterium is the causative agent of bovine tuberculosis, a chronic infectious disease that primarily affects the lungs but can spread to other organs. Diagnostic methods include skin tests, such as the tuberculin skin test, blood tests, and advanced molecular techniques like polymerase chain reaction (PCR).
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Bovine Tuberculosis Diagnosis Market Size in 2023: | USD 795.5 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 7.5% |
2032 Value Projection: | USD 1.5 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 135 |
Tables, Charts & Figures: | 159 |
Segments covered: | Type, Sample Type, End Use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|